TORONTO, May 15, 2017 /CNW/ - In response to investor and
media inquiries received about the operations and partnership
activities at its Virginia-based
Innovative Diagnostic Laboratory ("IDL") clinical reference lab,
GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today
announced that its Chairman and CEO, James
Howard-Tripp, will host a conference call at 4:30 p.m. ET on Thursday,
May 18, 2017 to discuss IDL's business.
IDL Business Update Conference Call Details:
|
Date:
Thursday, May 18, 2017
|
|
|
Time: 4:30
p.m. ET
|
|
|
Live Call:
(888) 231-8191 (Canada and the United States)
|
|
(647) 427-7450 (International)
|
|
Conference ID: 24600536
|
|
|
Replay: (855) 859-2056
(Canada and the United States)
|
|
(416) 849-0833 (International)
|
|
Password: 24600536
|
The call will also be broadcast live and archived on the
Company's website at www.GeneNews.com in the Investor's
section.
About GeneNews
GeneNews, an innovator in the liquid biopsy space, is committed
to becoming a leader in advanced diagnostics and personalized
medicine, serving as a strong commercialization outlet for early
detection of cancer and other chronic diseases. Our mission is to
identify, assess and make commercially available a comprehensive
menu of diagnostics that provide physicians and patients with
personalized clinical intelligence and actionable information to
improve health out-comes through the early diagnosis of
disease. Our Richmond,
Virginia-based Innovative Diagnostic Laboratory clinical
reference lab specializes in traditional and advanced clinical
evidence-based blood testing that helps find, understand, and
address cancer risk in patient populations. Currently, IDL offers
risk assessment blood tests for four prevalent cancer types -
colon, lung, prostate and breast. GeneNews' common shares trade on
the Toronto Stock Exchange under the symbol 'GEN'. More
information on GeneNews and IDL can be found at www.GeneNews.com
and www.myinnovativelab.com, respectively.
Forward-Looking Statements
This press release contains forward-looking statements
identified by words such as "expects", "will" and similar
expressions, which reflect the Company's current expectations
regarding future events. The forward-looking statements involve
risks and uncertainties that could cause the Company's actual
events to differ materially from those projected herein. Investors
should consult the Company's ongoing quarterly filings and annual
reports for additional information on risks and uncertainties
relating to these forward-looking statements. The reader is
cautioned not to rely on these forward-looking statements. The
Company disclaims any obligation to update these forward-looking
statements, except as required by law.
SOURCE GeneNews Limited